The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121468202 12146820 2 F 20160212 20160711 20160304 20160726 PER US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-013531 BRISTOL MYERS SQUIBB 68.68 YR F Y 0.00000 20160726 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121468202 12146820 1 PS OPDIVO NIVOLUMAB 1 Intravenous (not otherwise specified) 260 MG, Q2WK 45.6140366 MG U U AAF1096 125554 260 MG INJECTION QOW
121468202 12146820 2 SS ZOMETA ZOLEDRONIC ACID 1 Intravenous (not otherwise specified) 4 MG, / 28DAYS Y U 20191 0 4 MG
121468202 12146820 3 C ENALAPRIL ENALAPRIL 1 Unknown U U 0
121468202 12146820 4 C GLIMEPIRIDE. GLIMEPIRIDE 1 Unknown U U 0
121468202 12146820 5 C METFORMIN METFORMIN HYDROCHLORIDE 1 Unknown U U 0
121468202 12146820 6 C FLONASE /00908302/ MOMETASONE FUROATE 1 Unknown U U 0
121468202 12146820 7 C ZYRTEC CETIRIZINE HYDROCHLORIDE 1 Unknown U U 0
121468202 12146820 8 C LANTUS INSULIN GLARGINE 1 Unknown U U 0
121468202 12146820 9 C COMPAZINE PROCHLORPERAZINE MALEATE 1 Unknown U U 0
121468202 12146820 10 C ASA ASPIRIN 1 Unknown U U 0
121468202 12146820 11 C TESSALON BENZONATATE 1 Unknown U U 0
121468202 12146820 12 C HUMALOG INSULIN LISPRO 1 Unknown U U 0
121468202 12146820 13 C MORPHINE MORPHINE 1 Unknown U U 0
121468202 12146820 14 C PROBIOTIC /06395501/ BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS 1 Unknown U U 0
121468202 12146820 15 C PRILOSEC OMEPRAZOLE MAGNESIUM 1 Unknown U U 0
121468202 12146820 16 C DORZOLAMIDE/TIMOLOL /01419801/ DORZOLAMIDETIMOLOL 1 Unknown U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121468202 12146820 1 Lung cancer metastatic
121468202 12146820 2 Metastases to bone
121468202 12146820 3 Product used for unknown indication
121468202 12146820 4 Product used for unknown indication
121468202 12146820 5 Product used for unknown indication
121468202 12146820 6 Product used for unknown indication
121468202 12146820 7 Product used for unknown indication
121468202 12146820 8 Product used for unknown indication
121468202 12146820 9 Product used for unknown indication
121468202 12146820 10 Product used for unknown indication
121468202 12146820 11 Product used for unknown indication
121468202 12146820 12 Product used for unknown indication
121468202 12146820 13 Product used for unknown indication
121468202 12146820 14 Product used for unknown indication
121468202 12146820 15 Product used for unknown indication
121468202 12146820 16 Product used for unknown indication

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
121468202 12146820 Arthralgia
121468202 12146820 Pain
121468202 12146820 Peripheral swelling

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121468202 12146820 1 20160211 20160407 0
121468202 12146820 2 20160211 20160218 0